Evidence map›Paper›PMID 28370690›Full record

ArticleCell proliferation2017

Heat shock transcription factor 1 promotes the proliferation, migration and invasion of osteosarcoma cells.

Zhenhua Zhou, Yan Li, Qi Jia, Zhiwei Wang, Xudong Wang, Jingjing Hu, Jianru Xiao

Open access · bronzeAbstract read
In one paragraph

Article in Cell proliferation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. HSF1 and Its Role in Huntington's Disease Pathology.Advances in experimental medicine and biology · 2023
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. The Multifaceted Role of HSF1 in Tumorigenesis.Advances in experimental medicine and biology · 2020
    Review
  10. Network analysis ofCancer cell international · 2020
    Article
  11. HSF1 as a Cancer Biomarker and Therapeutic Target.Current cancer drug targets · 2019
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zhenhua ZhouDepartment of Orthopaedic Oncology, Changzheng Hospital, The Second Military Medical University, Shanghai, China.
Yan LiDepartment of Oncology, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China.
Qi JiaDepartment of Orthopaedic Oncology, Changzheng Hospital, The Second Military Medical University, Shanghai, China.
Zhiwei WangDepartment of Orthopedics, Changhai Hospital, The Second Military Medical University, Shanghai, China.
Xudong WangDepartment of Orthopaedic Oncology, Changzheng Hospital, The Second Military Medical University, Shanghai, China.
Jingjing HuCenter for Translational Medicine, Changhai Hospital, The Second Military Medical University, Shanghai, China.
Jianru XiaoDepartment of Orthopaedic Oncology, Changzheng Hospital, The Second Military Medical University, Shanghai, China.ORCID http://orcid.org/0000-0002-5943-2655
Second Military Medical University · CNFudan University Shanghai Cancer Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesOsteosarcoma is the most commonly diagnosed primary malignancy of bone and its overall survival rate is still very low. The molecular mechanisms underlying the progression of osteosarcoma have not been clearly illuminated. Heat shock transcription factor 1 (HSF1) is a key regulator of the heat shock response and also plays important roles in many cancers, but its function in osteosarcoma remains unexplored. MATERIALS AND

methodsIn this study, the proliferation of osteosarcoma cells was determined by Cell Counting Kit-8 assays and colony formation assays. Transwell assays were used to demonstrate the migration and invasion abilities of osteosarcoma cells. A tumour formation assay in a nude mouse model was performed to assess the effect of HSF1 on osteosarcoma cell growth in vivo. The protein levels of HSF1 were analysed with immunohistochemical staining in samples from osteosarcoma patients.

resultsWe demonstrated that knockdown of HSF1 reduced the proliferation, migration and invasion of osteosarcoma cells, while overexpression of HSF1 promoted the proliferation, migration and invasion of osteosarcoma cells. Furthermore, HSF1 promoted the proliferation of osteosarcoma cells in vivo. In addition, high levels of HSF1 were associated with a poor prognosis in osteosarcoma.

conclusionsThese data highlight an important role of HSF1 in proliferation, migration and invasion of osteosarcoma cells. Moreover, the expression of HSF1 was associated with prognosis in osteosarcoma.

Indexed as

AdolescentAdultAnimalsCell Line, TumorCell MovementCell ProliferationChildDNA-Binding ProteinsFemaleGenetic VectorsHeat Shock Transcription FactorsHEK293 CellsHumansMaleMiceMice, Inbred BALB CDNA-Binding ProteinsHeat Shock Transcription FactorsHSF1 protein, humanRNA, Small InterferingTranscription Factorsheat shock transcription factor 1invasionmigrationosteosarcomaprognosisproliferation

Identifiers

PMID28370690
PMCPMC6529100
OpenAlexW2604823546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.